Teva Pharmaceuticals USA IncReport Error
PTAB
| IPR2022-01513 | 2022-09-09 | Final Written Decision | Medical | Bayer Pharma AG | Invagen Pharmaceuticals Inc Mylan Pharmaceuticals Inc Teva Pharmaceuticals USA Inc |
| IPR2022-01515 | 2022-09-08 | Final Written Decision | Medical | Bayer Pharma AG | Invagen Pharmaceuticals Inc Mylan Pharmaceuticals Inc Teva Pharmaceuticals USA Inc |
| IPR2022-00517 | 2022-02-02 | Final Written Decision | Medical | Bayer Pharma AG | Invagen Pharmaceuticals Inc Mylan Pharmaceuticals Inc Teva Pharmaceuticals USA Inc |
| IPR2020-01045 | 2020-06-10 | Final Written Decision | Medical | Merck Sharp & Dohme LLC Merck, Sharpe & Dohme Corp | Watson Laboratories Inc Teva Pharmaceuticals USA Inc |
| IPR2020-00040 | 2019-10-30 | Settlement | Medical | Merck Sharp & Dohme LLC Merck, Sharpe & Dohme Corp | Watson Laboratories Inc Sun Pharmaceuticals Industries Ltd Mylan Pharmaceuticals Inc Dr Reddys Laboratories Inc Sun Pharmaceutical Industries Ltd Teva Pharmaceuticals USA Inc |
| PGR2019-00048 | 2019-05-07 | Final Written Decision | Medical | Corcept Therapeutics Inc | Teva Pharmaceutical Industries Ltd Teva Pharmaceuticals USA Inc |
Ex-Parte Reexams
Litigation
Patents
| WO-2024073716-A3 | Cd38-binding Fusion Protein Combination Therapy | 2024-06-13 | 2022-09-29 | Pogue Sarah Arana Therapeutics Inc Cephalon LLC Takeda Pharmaceuticals Co Teva Pharmaceuticals Australia Pty Ltd |
| WO-2024097938-A1 | Compositions and Methods for Increasing Transport into the Brain | 2024-05-10 | 2022-11-04 | Cephalon LLC Arana Therapeutics Inc |
| US-20240150447-A1 | Compositions and Methods for Increasing Transport into the Brain | 2024-05-09 | 2022-11-04 | Cephalon LLC Arana Therapeutics Inc |
| WO-2024073716-A2 | Cd38-binding Fusion Protein Combination Therapy | 2024-04-04 | 2022-09-29 | Cephalon LLC Arana Therapeutics Inc Takeda Pharmaceuticals Co Pogue Sarah Teva Pharmaceuticals Australia Pty Ltd |
| CN-101076542-A | Antibodies Specific for Hepatocellular Carcinoma and Other Carcinomas and Uses Thereof | 2007-11-21 | 2004-09-13 | Arana Therapeutics Inc Ivo Nicks Zhan Ltd by Share Ltd |
| EP-1720908-A2 | Super-humanized Antibodies Against Respiratory Syncytial Virus | 2006-11-15 | 2004-02-17 | Arana Therapeutics Inc |
| WO-2006029459-A1 | Antibodies Specific for Hepatocellular Carcinoma and Other Carcinomas and Uses Thereof | 2006-03-23 | 2004-09-13 | Ivo Nicks Zhan Ltd by Share Ltd Arana Therapeutics Inc |
| WO-2005079479-A3 | Super-humanized Antibodies Against Respiratory Syncytial Virus | 2006-01-12 | 2004-02-17 | Arana Therapeutics Inc |
| US-20050288491-A1 | Super-humanized Antibodies Against Respiratory Syncytial Virus | 2005-12-29 | 2004-02-17 | Arana Therapeutics Inc |
| AU-2005214988-A1 | Super-humanized Antibodies Against Respiratory Syncytial Virus | 2005-09-01 | 2004-02-17 | Arana Therapeutics Inc |
| WO-2005079479-A2 | Super-humanized Antibodies Against Respiratory Syncytial Virus | 2005-09-01 | 2004-02-17 | Arana Therapeutics Inc |